A phase I clinical trial to evaluate the safety, tolerability, and pharmacodynamics of AST-005 in patients with chronic plaque psoriasis
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2016
At a glance
- Drugs AST 005 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- 12 Dec 2016 According to a Purdue Pharma media release, status changed from recruiting to completed.
- 29 Apr 2016 New trial record
- 26 Apr 2016 Topline results from trial trial are expected later this year, according to an Exicure media release.